Ein 53-jähriger Mann aus der südlichen Region von Sri Lanka stellte sich mit seit 2 Wochen bestehenden schmerzhaften, scharf begrenzten, hyperpigmentierten, indurierten Plaques sowohl am Hals als auch symmetrisch verteilt an den Unterarmen und Unterschenkeln vor. Er berichtete über eine Größenzunahme und Brennen der Hautläsionen nach Sonnenlichtexposition sowie über ein enorales Brennen. Darüber hinaus beklagte die Ehefrau des Patienten eine zunehmende Vergesslichkeit des Ehemannes seit etwa 3 Wochen. Der Patient konsumierte regelmäßig Alkohol und vernachlässigte teilweise dieNahrungsaufnahmewährend der Alkoholintoxikation, eine Diarrhö oder Tuberkulose lagen hingegen nicht vor.

The number of Trichophyton quinckeanum infections has increased significantly in recent years. In 2020 in particular, the number of cases increased fivefold compared to 2015. Infections multiplied, especially in the second half of the year, which correlated with the upsurge in field mouse populations. Typical vectors are mice and rats as well as dogs and cats, which hunt the rodents. The animals are usually asymptomatic. In humans, on the other hand, the course is usually more inflammatory corresponding to other zoophilic mycoses. Typical clinical manifestations of the infections are tinea corporis and tinea capitis. Treatment of T. quinckeanum infections is similar to other dermatophyte infections, depending on the severity, location and age of the patient as well as the immune status, previous illnesses and medication. The duration of local therapy should be at least 4 weeks and continued for up to 14 days after the normalization of the skin presentation. Systemic treatment should take place with terbinafine 250 mg once a day orally (in adults). Alternatives are itraconazole, fluconazole and griseofulvin. Only the preparation griseofulvin, which is no longer available in Germany, is approved for children. Alternatively, terbinafine, itraconazole or fluconazole can also be used in children as an "off-label" treatment in an individual healing attempt.

BACKGROUND:Wound healing after pectoral port implantation is a major factor determining the success or failure of the procedure. Infection and wound dehiscence can endanger the functionality of the port system and impede chemotherapy. The cosmetic result is important for patient satisfaction as well.METHODS:From August 2015 to July 2017, adult patients with an indication for port implantation were entered into a prospective, randomized and controlled single-center study. The skin incision was closed either with tissue adhesive or with an intracutaneous suture. The primary endpoints were the total score of the scar evaluated by the patient and the investigator on the POSAS scale (Patient and Observer Scar Assessment Scale: 6 [normal skin] to 60 points), blinded assessment of photographic documentation by ten evaluating physicians, and the patient's reported quality of life. The calculation of case numbers was based only on the patients' overall POSAS assessment, which was tested for non-inferiority. The secondary endpoints were other complications (infection, dehiscence) and the duration of wound closure (trial registration number NCT02551510).RESULTS:156 patients (60 ± 13 years, 64% women) participated in the study. The patient-assessed total POSAS score of tissue adhesive revealed non-inferiority to suturing (adhesive 11.7 ± 5.8 vs. suture 10.1 ± 4.0, p for non-inferiority <0.001). Both the investigators in their POSAS assessments and the blinded physician evaluators in their assessment of photographically documented wounds rated wound closure by suturing better than closure with tissue adhesive. No significant differences were found between groups with respect to quality of life or the frequency of wound infection or dehiscence.CONCLUSION:Closure of the upper cutaneous layer with tissue adhesive is a suitable and safe method of wound closure after port implantation.

Infektionen mit Trichophyton (T.) quinckeanum haben in den letzten Jahren deutlich zugenommen. Insbesondere im Jahr 2020 haben sich die Fälle gegenüber 2015 verfünffacht. Vor allem in der zweiten Jahreshälfte sind vermehrt Infektionen aufgetreten, was mit dem Anstieg von Feldmauspopulationen korrelierte. Typische Vektoren sind Mäuse und Ratten sowie Hunde und Katzen, welche die Nagetiere jagen. Die Tiere sind in aller Regel asymptomatisch. Beim Menschen hingegen ist der Verlauf – wie bei anderen zoophilen Mykosen – meist stärker entzündlich als bei anthropophilen Erregern. Typische klinische Manifestationen der Infektionen sind Tinea corporis und Tinea capitis. Die Therapie von T.-quinckeanum-Infektionen erfolgt analog zu anderen Dermatophyteninfektionen in Abhängigkeit von Ausprägung, Lokalisation und Alter des Patienten sowie Immunstatus, Vorerkrankungen und Medikation. Die Therapiedauer einer Lokaltherapie sollte mindestens 4 Wochen betragen und sicherheitshalber noch bis 14 Tage über die Normalisierung des Hautbefundes hinaus fortgeführt werden. Die systemische Behandlung sollte mit Terbinafin 250 mg 1‑mal täglich oral (bei Erwachsenen) erfolgen. Alternativen sind Itraconazol, Fluconazol und Griseofulvin. Für Kinder ist nur das Präparat Griseofulvin zugelassen, das in Deutschland nicht mehr lieferbar ist. Alternativ kann auch bei Kindern Terbinafin, Itraconazol oder Fluconazol in einem individuellen Heilversuch als Off-label-Anwendung eingesetzt werden.

Adverse reactions to sunscreens are uncommon in relation to their widespread use [Loden et al. Br J Dermatol. 2011;165(2):255-62; Jansen et al. J Am Acad Dermatol. 2013;69(6):867 e861-814; quiz 881-862] and can be related to both active and inactive ingredients in sunscreen products [DiNardo et al. J Cosmet Dermatol. 2018;17(1):15-19; Barrientos et al. Contact Dermatitis. 2019;81(2):151-52]. Pathogenetically, the main cutaneous adverse reaction patterns to sunscreens can be divided into allergic and irritant contact dermatitis, phototoxic and photoallergic contact dermatitis, contact urticaria, and, in solitary cases, anaphylactic reactions [Lautenschlager et al. Lancet. 2007;370(9586):528-37]. A summary is provided in Table 1. Nearly all adverse effects due to active sunscreen ingredients reported to date are related to the organic UV filters, which are sometimes also referred to as "chemical UV filters." This imbalance is attributable to the lipophilic character and small molecular size of the organic UV filters that allow skin penetration, which is the basic requirement to initiate the sensitization [Stiefel et al. Int J Cosmet Sci. 2015;37(1):2-30]. In contrast, cutaneous adverse reactions to inorganic UV filters, initially termed "physical UV filters" owing to their firstly known "physical" mechanism of action through reflection and scattering [Stiefel et al. Int J Cosmet Sci. 2015;37(1):2-30], are only reported by case reports. Neither zinc oxide nor titanium dioxide possesses relevant skin-irritating properties or sensitization potential [Lau-tenschlager et al. Lancet. 2007;370(9586):528-37]. Adverse reactions to UV filters currently approved in the European Union as listed in the Annex VI (updated November 7, 2019) are summarized in Table 2.

Background: Wound healing after pectoral port implantation is a major factor determining the success or failure of the pro-cedure. Infection and wound dehiscence can endanger the functionality of the port system and impede chemotherapy. The cosmetic result is important for patient satisfaction as well. Methods: From August 2015 to July 2017, adult patients with an indication for port implantation were entered into a prospective, randomized and controlled single-center study. The skin incision was closed either with tissue adhesive or with an intracu-taneous suture. The primary endpoints were the total score of the scar evaluated by the patient and the investigator on the POSAS scale (Patient and Observer Scar Assessment Scale: 6 [normal skin] to 60 points), blinded assessment of photographic documentation by ten evaluating physicians, and the patient's reported quality of life. The calculation of case numbers was based only on the patients' overall POSAS assessment, which was tested for non-inferiority. The secondary endpoints were other complications (infection, dehiscence) and the duration of wound closure (trial registration number NCT02551510). Results: 156 patients (60 +/- 13 years, 64% women) participated in the study. The patient-assessed total POSAS score of tissue adhesive revealed non-inferiority to suturing (adhesive 11.7 +/- 5.8 vs. suture 10.1 +/- 4.0, p for non-inferiority <0.001). Both the investigators in their POSAS assessments and the blinded physician evaluators in their assessment of photographically docu-mented wounds rated wound closure by suturing better than closure with tissue adhesive. No significant differences were found between groups with respect to quality of life or the frequency of wound infection or dehiscence. Conclusion: Closure of the upper cutaneous layer with tissue adhesive is a suitable and safe method of wound closure after port implantation.

On the occasion of the 95th anniversary of the Department of Dermatology Jena this article sheds light on the historical development of the house in the different political systems of the last century as well as the current situation of the clinic as part of the University Hospital Jena. Various clinicians in the past have shaped the house's focus on therapy and research, focusing on topics such as phototherapy, autoimmune diseases, dermatooncology, andrology, and biomaterials research. The University Department of Dermatology combines not only high-quality patient care and teaching, but also extensive research activities.

JDDG: Journal der Deutschen Dermatologischen GesellschaftVolume 18, Issue 7 p. 740-742 Clinical LetterOpen Access Behandlung einer Patientin mit atopischem Ekzem nach Lebertransplantation mit Dupilumab: Fallbericht Laine Ludriksone, Corresponding Author Laine Ludriksone laine.ludriksone@med.uni-jena.de Hautklinik, Universitätsklinikum Jena Korrespondenzanschrift Laine Ludriksone Hautklinik Universitätsklinikum Jena Erfurter Straße 35 07743 Jena E-Mail: laine.ludriksone@med.uni-jena.deSearch for more papers by this authorPeter Elsner, Peter Elsner Hautklinik, Universitätsklinikum JenaSearch for more papers by this authorChristina Malessa, Christina Malessa Klinik für Allgemein-, Viszeral- und Gefäßchirurgie, Universitätsklinikum JenaSearch for more papers by this authorUtz Settmacher, Utz Settmacher Klinik für Allgemein-, Viszeral- und Gefäßchirurgie, Universitätsklinikum JenaSearch for more papers by this authorSibylle Schliemann, Sibylle Schliemann Hautklinik, Universitätsklinikum JenaSearch for more papers by this author Laine Ludriksone, Corresponding Author Laine Ludriksone laine.ludriksone@med.uni-jena.de Hautklinik, Universitätsklinikum Jena Korrespondenzanschrift Laine Ludriksone Hautklinik Universitätsklinikum Jena Erfurter Straße 35 07743 Jena E-Mail: laine.ludriksone@med.uni-jena.deSearch for more papers by this authorPeter Elsner, Peter Elsner Hautklinik, Universitätsklinikum JenaSearch for more papers by this authorChristina Malessa, Christina Malessa Klinik für Allgemein-, Viszeral- und Gefäßchirurgie, Universitätsklinikum JenaSearch for more papers by this authorUtz Settmacher, Utz Settmacher Klinik für Allgemein-, Viszeral- und Gefäßchirurgie, Universitätsklinikum JenaSearch for more papers by this authorSibylle Schliemann, Sibylle Schliemann Hautklinik, Universitätsklinikum JenaSearch for more papers by this author First published: 26 July 2020 https://doi.org/10.1111/ddg.14074_gCitations: 3AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat No abstract is available for this article.Citing Literature Volume18, Issue7July 2020Pages 740-742 RelatedInformation

JDDG: Journal der Deutschen Dermatologischen GesellschaftVolume 18, Issue 3 p. 263-265 Clinical Letter Eyelid edema as first manifestation of anti-MDA5 positive dermatomyositis with rapidly progressive interstitial lung disease: A case report Laine Ludriksone, Corresponding Author Laine Ludriksone laine.ludriksone@med.uni-jena.de Department of Dermatology, University Hospital Jena, Jena, Germany Correspondence to Laine Ludriksone Department of Dermatology University Hospital Jena Erfurter Strasse 35 07743 Jena, Germany E-mail: laine.ludriksone@med.uni-jena.deSearch for more papers by this authorAlexander Pfeil, Alexander Pfeil Department of Rheumatology, Clinic of Internal Medicine, University Hospital Jena, Jena, GermanySearch for more papers by this authorSibylle Schliemann, Sibylle Schliemann Department of Dermatology, University Hospital Jena, Jena, GermanySearch for more papers by this authorPeter Elsner, Peter Elsner orcid.org/0000-0001-7696-3274 Department of Dermatology, University Hospital Jena, Jena, GermanySearch for more papers by this author Laine Ludriksone, Corresponding Author Laine Ludriksone laine.ludriksone@med.uni-jena.de Department of Dermatology, University Hospital Jena, Jena, Germany Correspondence to Laine Ludriksone Department of Dermatology University Hospital Jena Erfurter Strasse 35 07743 Jena, Germany E-mail: laine.ludriksone@med.uni-jena.deSearch for more papers by this authorAlexander Pfeil, Alexander Pfeil Department of Rheumatology, Clinic of Internal Medicine, University Hospital Jena, Jena, GermanySearch for more papers by this authorSibylle Schliemann, Sibylle Schliemann Department of Dermatology, University Hospital Jena, Jena, GermanySearch for more papers by this authorPeter Elsner, Peter Elsner orcid.org/0000-0001-7696-3274 Department of Dermatology, University Hospital Jena, Jena, GermanySearch for more papers by this author First published: 10 January 2020 https://doi.org/10.1111/ddg.14014Citations: 2AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article.Citing Literature Volume18, Issue3March 2020Pages 263-265 RelatedInformation

JDDG: Journal der Deutschen Dermatologischen GesellschaftVolume 18, Issue 3 p. 262-264 Clinical Letter Lidödem als erstes Symptom bei anti-MDA5 positiver Dermatomyositis mit schnell progressiver interstitieller Lungenerkrankung: ein Fallbericht Laine Ludriksone, Corresponding Author Laine Ludriksone laine.ludriksone@med.uni-jena.de Hautklinik, Universitätsklinikum Jena Korrespondenzanschrift Laine Ludriksone Hautklinik Universitätsklinikum Jena Erfurter Straße 35 07743 Jena E-Mail: laine.ludriksone@med.uni-jena.deSearch for more papers by this authorAlexander Pfeil, Alexander Pfeil Funktionsbereich Rheumatologie und Osteologie, Klinik für Innere Medizin III, Universitätsklinikum JenaSearch for more papers by this authorSibylle Schliemann, Sibylle Schliemann Hautklinik, Universitätsklinikum JenaSearch for more papers by this authorPeter Elsner, Peter Elsner orcid.org/0000-0001-7696-3274 Hautklinik, Universitätsklinikum JenaSearch for more papers by this author Laine Ludriksone, Corresponding Author Laine Ludriksone laine.ludriksone@med.uni-jena.de Hautklinik, Universitätsklinikum Jena Korrespondenzanschrift Laine Ludriksone Hautklinik Universitätsklinikum Jena Erfurter Straße 35 07743 Jena E-Mail: laine.ludriksone@med.uni-jena.deSearch for more papers by this authorAlexander Pfeil, Alexander Pfeil Funktionsbereich Rheumatologie und Osteologie, Klinik für Innere Medizin III, Universitätsklinikum JenaSearch for more papers by this authorSibylle Schliemann, Sibylle Schliemann Hautklinik, Universitätsklinikum JenaSearch for more papers by this authorPeter Elsner, Peter Elsner orcid.org/0000-0001-7696-3274 Hautklinik, Universitätsklinikum JenaSearch for more papers by this author First published: 04 March 2020 https://doi.org/10.1111/ddg.14014_gAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article. Volume18, Issue3March 2020Pages 262-264 RelatedInformation

JDDG: Journal der Deutschen Dermatologischen GesellschaftVolume 18, Issue 7 p. 740-742 Clinical LetterOpen Access Effectiveness and safety of dupilumab for atopic dermatitis in a liver transplant recipient: a case report Laine Ludriksone, Corresponding Author Laine Ludriksone laine.ludriksone@med.uni-jena.de Department of Dermatology, University Hospital Jena, Jena, Germany Correspondence to Laine Ludriksone Department of Dermatology University Hospital Jena Erfurter Strasse 35 07743 Jena, Germany E-mail: laine.ludriksone@med.uni-jena.deSearch for more papers by this authorPeter Elsner, Peter Elsner Department of Dermatology, University Hospital Jena, Jena, GermanySearch for more papers by this authorChristina Malessa, Christina Malessa Department of General, Visceral and Vascular Surgery, University Hospital Jena, Jena, GermanySearch for more papers by this authorUtz Settmacher, Utz Settmacher Department of General, Visceral and Vascular Surgery, University Hospital Jena, Jena, GermanySearch for more papers by this authorSibylle Schliemann, Sibylle Schliemann Department of Dermatology, University Hospital Jena, Jena, GermanySearch for more papers by this author Laine Ludriksone, Corresponding Author Laine Ludriksone laine.ludriksone@med.uni-jena.de Department of Dermatology, University Hospital Jena, Jena, Germany Correspondence to Laine Ludriksone Department of Dermatology University Hospital Jena Erfurter Strasse 35 07743 Jena, Germany E-mail: laine.ludriksone@med.uni-jena.deSearch for more papers by this authorPeter Elsner, Peter Elsner Department of Dermatology, University Hospital Jena, Jena, GermanySearch for more papers by this authorChristina Malessa, Christina Malessa Department of General, Visceral and Vascular Surgery, University Hospital Jena, Jena, GermanySearch for more papers by this authorUtz Settmacher, Utz Settmacher Department of General, Visceral and Vascular Surgery, University Hospital Jena, Jena, GermanySearch for more papers by this authorSibylle Schliemann, Sibylle Schliemann Department of Dermatology, University Hospital Jena, Jena, GermanySearch for more papers by this author First published: 25 March 2020 https://doi.org/10.1111/ddg.14074Citations: 3AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat No abstract is available for this article.Citing Literature Volume18, Issue7July 2020Pages 740-742 RelatedInformation

ZusammenfassungAnlässlich des 95-jährigen Jubiläums der Universitäts-Hautklinik Jena beleuchtet dieser Beitrag die historische Entwicklung des Hauses in den verschiedenen politischen Systemen des letzten Jahrhunderts sowie die aktuelle Situation der Klinik als Teil des Universitätsklinikums Jena. Verschiedene Klinikleitungen in der Vergangenheit prägten die Ausrichtung des Hauses in Bezug auf Therapie und Forschung und setzten Schwerpunkte auf Themen wie Phototherapie, Autoimmunerkrankungen, Dermatoonkologie, Andrologie und Biomaterialforschung. Die Universitäts-Hautklinik vereint neben hochqualitativer Patientenversorgung und Lehre umfangreiche Forschungsaktivitäten.

Journal of the European Academy of Dermatology and VenereologyVolume 33, Issue 12 p. e482-e483 Letter to the Editor Acquired hypersensitivity to dupilumab: first case report L. Ludriksone, Corresponding Author L. Ludriksone laine.ludriksone@med.uni-jena.de orcid.org/0000-0003-0377-8283 Department of Dermatology, University Hospital Jena, Jena, GermanyCorrespondence: L. Ludriksone. E-mail: laine.ludriksone@med.uni-jena.deSearch for more papers by this authorP. Elsner, P. Elsner Department of Dermatology, University Hospital Jena, Jena, GermanySearch for more papers by this authorS. Schliemann, S. Schliemann Department of Dermatology, University Hospital Jena, Jena, GermanySearch for more papers by this author L. Ludriksone, Corresponding Author L. Ludriksone laine.ludriksone@med.uni-jena.de orcid.org/0000-0003-0377-8283 Department of Dermatology, University Hospital Jena, Jena, GermanyCorrespondence: L. Ludriksone. E-mail: laine.ludriksone@med.uni-jena.deSearch for more papers by this authorP. Elsner, P. Elsner Department of Dermatology, University Hospital Jena, Jena, GermanySearch for more papers by this authorS. Schliemann, S. Schliemann Department of Dermatology, University Hospital Jena, Jena, GermanySearch for more papers by this author First published: 16 July 2019 https://doi.org/10.1111/jdv.15807Citations: 5Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article.Citing Literature Volume33, Issue12December 2019Pages e482-e483 RelatedInformation

JDDG: Journal der Deutschen Dermatologischen GesellschaftVolume 17, Issue 12 p. 1278-1280 Clinical Letter Simultaneous effectiveness of dupilumab in atopic dermatitis and alopecia areata in two patients Laine Ludriksone, Corresponding Author Laine Ludriksone laine.ludriksone@med.uni-jena.de Department of Dermatology, University Hospital Jena, Jena, Germany Correspondence to Laine Ludriksone Department of Dermatology University Hospital Jena Erfurter Strasse 35 07743 Jena, Germany E-mail: laine.ludriksone@med.uni-jena.deSearch for more papers by this authorPeter Elsner, Peter Elsner orcid.org/0000-0001-7696-3274 Department of Dermatology, University Hospital Jena, Jena, GermanySearch for more papers by this authorSibylle Schliemann, Sibylle Schliemann Department of Dermatology, University Hospital Jena, Jena, GermanySearch for more papers by this author Laine Ludriksone, Corresponding Author Laine Ludriksone laine.ludriksone@med.uni-jena.de Department of Dermatology, University Hospital Jena, Jena, Germany Correspondence to Laine Ludriksone Department of Dermatology University Hospital Jena Erfurter Strasse 35 07743 Jena, Germany E-mail: laine.ludriksone@med.uni-jena.deSearch for more papers by this authorPeter Elsner, Peter Elsner orcid.org/0000-0001-7696-3274 Department of Dermatology, University Hospital Jena, Jena, GermanySearch for more papers by this authorSibylle Schliemann, Sibylle Schliemann Department of Dermatology, University Hospital Jena, Jena, GermanySearch for more papers by this author First published: 12 December 2019 https://doi.org/10.1111/ddg.13990Citations: 6AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article.Citing Literature Volume17, Issue12December 2019Pages 1278-1280 RelatedInformation

JDDG: Journal der Deutschen Dermatologischen GesellschaftVolume 17, Issue 12 p. 1278-1280 Clinical Letter Gleichzeitige Wirksamkeit von Dupilumab bei atopischer Dermatitis und Alopecia areata bei zwei Patienten Laine Ludriksone, Corresponding Author Laine Ludriksone laine.ludriksone@med.uni-jena.de Klinik für Hautkrankheiten, Universitätsklinikum Jena, Jena, Deutschland Korrespondenzanschrift Laine Ludriksone Klinik für Hautkrankheiten Universitätsklinikum Jena Erfurter Straße 35 07743 Jena E-Mail: laine.ludriksone@med.uni-jena.deSearch for more papers by this authorPeter Elsner, Peter Elsner orcid.org/0000-0001-7696-3274 Klinik für Hautkrankheiten, Universitätsklinikum Jena, Jena, DeutschlandSearch for more papers by this authorSibylle Schliemann, Sibylle Schliemann Klinik für Hautkrankheiten, Universitätsklinikum Jena, Jena, DeutschlandSearch for more papers by this author Laine Ludriksone, Corresponding Author Laine Ludriksone laine.ludriksone@med.uni-jena.de Klinik für Hautkrankheiten, Universitätsklinikum Jena, Jena, Deutschland Korrespondenzanschrift Laine Ludriksone Klinik für Hautkrankheiten Universitätsklinikum Jena Erfurter Straße 35 07743 Jena E-Mail: laine.ludriksone@med.uni-jena.deSearch for more papers by this authorPeter Elsner, Peter Elsner orcid.org/0000-0001-7696-3274 Klinik für Hautkrankheiten, Universitätsklinikum Jena, Jena, DeutschlandSearch for more papers by this authorSibylle Schliemann, Sibylle Schliemann Klinik für Hautkrankheiten, Universitätsklinikum Jena, Jena, DeutschlandSearch for more papers by this author First published: 30 December 2019 https://doi.org/10.1111/ddg.13990_gCitations: 2AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article.Citing Literature Volume17, Issue12December 2019Pages 1278-1280 RelatedInformation